|
|
News Breaks | | | | March 13, 2013 | | 07:35 EDT |  | IBIO | iBio to receive new patent to add to iBioModulator portfolio
iBio announced notification from the U.S. Patent and Trademark Office that a new patent in the Company's iBioModulator portfolio will issue on March 26. The new patent, number 8,404,252 entitled "Yersinia pestis Antigens, Vaccine Compositions and Related Methods," includes claims covering plague antigens fused to the Company's thermostable immunomodulator -- iBioModulator -- protein, as well as vaccine compositions and a method for producing a protective immune response to the antigen. | |
|
News For IBIO From The Last 14 Days Check below for free stories on IBIO the last two weeks. |
|
|
| June 13, 2013 | | 17:25 EDT | | IBIO | E. Gerald Kay reports 10.49% stake in iBio
| | | 17:09 EDT | | IBIO | Carl DeSantis reports 8.89% stake in iBio
 Subscribe for More Information | | | June 10, 2013 | | 07:31 EDT | | IBIO | iBio adds Chinese patent for anthrax antibody
Subscribe for More Information | | | June 5, 2013 | | 07:32 EDT | | IBIO | iBio receives notice that NYSE has accepted plan to regain compliance
Subscribe for More Information | |
|
|
|
|
|
|
